🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
The goal of this clinical trial is to evaluate whether hypofractionated who...
Status
Recruiting
Location
Siriraj Hospital
Start Date
2026-08-03
Trial ID
NCT07709650
Treatments Being Tested
The objective of the present study is to evaluate the effectiveness of post...
Status
Withdrawn
Location
Sunnybrook Health Sciences Centre
Start Date
2020-10
Trial ID
NCT04109937
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Washington Cancer Institute at Washington Hospital Center
Start Date
1999-08
Trial ID
NCT00006469
Treatments Being Tested
This study will look at how feasible it is to use a certain type of Compute...
Status
Completed
Location
University Health Network, The Princess Margaret
Start Date
2012-10
Trial ID
NCT01878773
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of the two most ...
Status
Suspended
Location
Multiple Locations
Start Date
1997-01
Trial ID
NCT02091661
Treatments Being Tested
This phase III trial compares stereotactic body radiation therapy (SBRT), (...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-12-14
Trial ID
NCT05946213
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested
This will be the first study to assess the clinical feasibility of dose esc...
Status
Completed
Location
Saint Bartholomew's Hospital
Start Date
2010-07
Trial ID
NCT01230996
Treatments Being Tested
This phase III trial compares whether the addition of pembrolizumab to radi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-04-09
Trial ID
NCT04214067